Therapix Biosciences Ltd.
TRPX
TRPX was delisted on the 1st of July, 2020.
6 hedge funds and large institutions have $202K invested in Therapix Biosciences Ltd. in 2017 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 2 reducing their positions, and 2 closing their positions.
11% more capital invested
Capital invested by funds: $182K → $202K (+$20K)
14% less funds holding
Funds holding: 7 → 6 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AG
Advisor Group
Phoenix,
Arizona
|
+$59.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$5.99K |
| 2 |
Jane Street
New York
|
-$1.44K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Jane Street
New York
| $77K | -$1.44K | -241 | -2% |
|
|
2
Morgan Stanley
New York
| $59K | -$5.99K | -1,000 | -9% |
|
|
AG
3
Advisor Group
Phoenix,
Arizona
| $58K | +$59.9K | +10,000 | New |
|
4
Royal Bank of Canada
Toronto,
Ontario, Canada
| $6K | – | – | – |
|
|
IA
5
IFP Advisors
Tampa,
Florida
| $1K | – | – | – |
|
|
PA
6
Parallel Advisors
San Francisco,
California
| $1K | – | – | – |
|
|
7
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$1K | -200 | Closed |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| – | -$1K | -100 | Closed |
|
TRPX Hedge Fund Activity: Q3 2017 in Review
6 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Therapix Biosciences Ltd. (TRPX) for Q3 2017, worth a combined $202K — up 11% from $182K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of TRPX and 1 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 0 added.
The largest buyer was Advisor Group, opening a new position worth an estimated $59.9K. The largest seller was Morgan Stanley, cutting an estimated $5.99K.
- 6 institutional investors held Therapix Biosciences Ltd. (TRPX) as of Q3 2017, down from 7 in Q2 2017.
- Funds reported $202K of Therapix Biosciences Ltd. stock for Q3 2017, up 11% quarter-over-quarter.
- 1 fund opened new Therapix Biosciences Ltd. positions in Q3 2017 and 2 closed out, a net change of -1 holder.
- The largest Therapix Biosciences Ltd. buyer in Q3 2017 was Advisor Group, an estimated $59.9K added.
- The largest Therapix Biosciences Ltd. seller in Q3 2017 was Morgan Stanley, an estimated $5.99K sold.
Based on aggregated 13F filings for Q3 2017.